CVS Health and Eli Lilly announce a push to improve GLP-1 access, as market watchers turn to second-quarter outlooks
A new collaboration between CVS Health and Eli Lilly is aimed at improving patient access to GLP-1 medicines, according to a report cited by Yahoo Finance, in a week when investors also scanned major healthcare names for second-quarter outlines.